BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

751 related articles for article (PubMed ID: 25503233)

  • 1. Genome-wide characterization of the routes to pluripotency.
    Hussein SM; Puri MC; Tonge PD; Benevento M; Corso AJ; Clancy JL; Mosbergen R; Li M; Lee DS; Cloonan N; Wood DL; Munoz J; Middleton R; Korn O; Patel HR; White CA; Shin JY; Gauthier ME; Lê Cao KA; Kim JI; Mar JC; Shakiba N; Ritchie W; Rasko JE; Grimmond SM; Zandstra PW; Wells CA; Preiss T; Seo JS; Heck AJ; Rogers IM; Nagy A
    Nature; 2014 Dec; 516(7530):198-206. PubMed ID: 25503233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic and genomic approaches reveal critical functions of H3K9 methylation and heterochromatin protein-1γ in reprogramming to pluripotency.
    Sridharan R; Gonzales-Cope M; Chronis C; Bonora G; McKee R; Huang C; Patel S; Lopez D; Mishra N; Pellegrini M; Carey M; Garcia BA; Plath K
    Nat Cell Biol; 2013 Jul; 15(7):872-82. PubMed ID: 23748610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent reprogramming routes lead to alternative stem-cell states.
    Tonge PD; Corso AJ; Monetti C; Hussein SM; Puri MC; Michael IP; Li M; Lee DS; Mar JC; Cloonan N; Wood DL; Gauthier ME; Korn O; Clancy JL; Preiss T; Grimmond SM; Shin JY; Seo JS; Wells CA; Rogers IM; Nagy A
    Nature; 2014 Dec; 516(7530):192-7. PubMed ID: 25503232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The H3K27 demethylase Utx regulates somatic and germ cell epigenetic reprogramming.
    Mansour AA; Gafni O; Weinberger L; Zviran A; Ayyash M; Rais Y; Krupalnik V; Zerbib M; Amann-Zalcenstein D; Maza I; Geula S; Viukov S; Holtzman L; Pribluda A; Canaani E; Horn-Saban S; Amit I; Novershtern N; Hanna JH
    Nature; 2012 Aug; 488(7411):409-13. PubMed ID: 22801502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reprogramming factor expression initiates widespread targeted chromatin remodeling.
    Koche RP; Smith ZD; Adli M; Gu H; Ku M; Gnirke A; Bernstein BE; Meissner A
    Cell Stem Cell; 2011 Jan; 8(1):96-105. PubMed ID: 21211784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concise review: Induced pluripotent stem cells versus embryonic stem cells: close enough or yet too far apart?
    Bilic J; Izpisua Belmonte JC
    Stem Cells; 2012 Jan; 30(1):33-41. PubMed ID: 22213481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromatin-modifying enzymes as modulators of reprogramming.
    Onder TT; Kara N; Cherry A; Sinha AU; Zhu N; Bernt KM; Cahan P; Marcarci BO; Unternaehrer J; Gupta PB; Lander ES; Armstrong SA; Daley GQ
    Nature; 2012 Mar; 483(7391):598-602. PubMed ID: 22388813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells.
    Lister R; Pelizzola M; Kida YS; Hawkins RD; Nery JR; Hon G; Antosiewicz-Bourget J; O'Malley R; Castanon R; Klugman S; Downes M; Yu R; Stewart R; Ren B; Thomson JA; Evans RM; Ecker JR
    Nature; 2011 Mar; 471(7336):68-73. PubMed ID: 21289626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells.
    Zhao MT; Shao NY; Hu S; Ma N; Srinivasan R; Jahanbani F; Lee J; Zhang SL; Snyder MP; Wu JC
    Circ Res; 2017 Nov; 121(11):1237-1250. PubMed ID: 29030344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual expression of reprogramming factors affects the transcriptional program and epigenetic signatures of induced pluripotent stem cells.
    Sommer CA; Christodoulou C; Gianotti-Sommer A; Shen SS; Sailaja BS; Hezroni H; Spira A; Meshorer E; Kotton DN; Mostoslavsky G
    PLoS One; 2012; 7(12):e51711. PubMed ID: 23272148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KDM4B-mediated reduction of H3K9me3 and H3K36me3 levels improves somatic cell reprogramming into pluripotency.
    Wei J; Antony J; Meng F; MacLean P; Rhind R; Laible G; Oback B
    Sci Rep; 2017 Aug; 7(1):7514. PubMed ID: 28790329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A PRC2-dependent repressive role of PRDM14 in human embryonic stem cells and induced pluripotent stem cell reprogramming.
    Chan YS; Göke J; Lu X; Venkatesan N; Feng B; Su IH; Ng HH
    Stem Cells; 2013 Apr; 31(4):682-92. PubMed ID: 23280602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamically reorganized chromatin is the key for the reprogramming of somatic cells to pluripotent cells.
    Huang K; Zhang X; Shi J; Yao M; Lin J; Li J; Liu H; Li H; Shi G; Wang Z; Zhang B; Chen J; Pan G; Jiang C; Pei D; Yao H
    Sci Rep; 2015 Dec; 5():17691. PubMed ID: 26639176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global transcriptional analysis of nuclear reprogramming in the transition from MEFs to iPSCs.
    Dong F; Song Z; Zhang J; Lu Y; Song C; Jiang B; Zhang B; Cong P; Sun H; Shi F; Liu H
    Genes Cells; 2013 Jan; 18(1):42-55. PubMed ID: 23231677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pluripotent state induction in mouse embryonic fibroblast using mRNAs of reprogramming factors.
    El-Sayed AK; Zhang Z; Zhang L; Liu Z; Abbott LC; Zhang Y; Li B
    Int J Mol Sci; 2014 Nov; 15(12):21840-64. PubMed ID: 25437916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem Cell Surface Marker Expression Defines Late Stages of Reprogramming to Pluripotency in Human Fibroblasts.
    Pomeroy JE; Hough SR; Davidson KC; Quaas AM; Rees JA; Pera MF
    Stem Cells Transl Med; 2016 Jul; 5(7):870-82. PubMed ID: 27160704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Returning to the stem state: epigenetics of recapitulating pre-differentiation chromatin structure.
    Shafa M; Krawetz R; Rancourt DE
    Bioessays; 2010 Sep; 32(9):791-9. PubMed ID: 20652894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the early and late responder genes during the generation of induced pluripotent stem cells from mouse fibroblasts.
    Park J; Kwon YW; Ham S; Hong CP; Seo S; Choe MK; Shin SI; Lee CS; Kim HS; Roh TY
    PLoS One; 2017; 12(2):e0171300. PubMed ID: 28152015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A late transition in somatic cell reprogramming requires regulators distinct from the pluripotency network.
    Golipour A; David L; Liu Y; Jayakumaran G; Hirsch CL; Trcka D; Wrana JL
    Cell Stem Cell; 2012 Dec; 11(6):769-82. PubMed ID: 23217423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replacement of Oct4 by Tet1 during iPSC induction reveals an important role of DNA methylation and hydroxymethylation in reprogramming.
    Gao Y; Chen J; Li K; Wu T; Huang B; Liu W; Kou X; Zhang Y; Huang H; Jiang Y; Yao C; Liu X; Lu Z; Xu Z; Kang L; Chen J; Wang H; Cai T; Gao S
    Cell Stem Cell; 2013 Apr; 12(4):453-69. PubMed ID: 23499384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.